Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.

Saved in:
Bibliographic Details
Title: Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Authors: Ben-Menachem E; Institute for Clinical Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Grebe HP; Department of Neurology, Hospital São Sebastião, Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal., Terada K; NHO Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan., Jensen L; UCB Pharma, Raleigh, NC, USA., Li T; UCB Pharma, Raleigh, NC, USA., De Backer M; UCB Pharma, Brussels, Belgium., Steiniger-Brach B; UCB Pharma, Brussels, Belgium., Gasalla T; UCB Pharma, Raleigh, NC, USA., Brock M; UCB Pharma, Raleigh, NC, USA., Biton V; Arkansas Epilepsy Program, Clinical Trials Inc, Little Rock, AR, USA.
Source: Epilepsia [Epilepsia] 2019 Dec; Vol. 60 (12), pp. 2437-2447. Date of Electronic Publication: 2019 Nov 21.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Equivalence Trial
Journal Info: Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1528-1167
DOI:10.1111/epi.16381